NCT01017666View on ClinicalTrials.gov

BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

November 1, 2009

Primary Completion Date

June 2, 2010

Study Completion Date

June 2, 2010

Conditions

Healthy

Interventions

DRUG

BIIB014

BIIB014 100mg PO Cohort 1 - 8d Cohort 2 - 14d

DRUG

Placebo

Matched placebo to BIIB014 Cohort 1 - 8d Cohort 2 - 14d

Trial Locations (1)

E14NL

InCROM Clinical Research Unit, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY